Search

Your search keyword '"Dueker, Jeffrey"' showing total 190 results

Search Constraints

Start Over You searched for: Author "Dueker, Jeffrey" Remove constraint Author: "Dueker, Jeffrey"
190 results on '"Dueker, Jeffrey"'

Search Results

1. Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease With Active or Recent Malignancy: A Multi-Center Cohort Study

2. KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy

3. Teaching and Assessing the Responsible Conduct of Research: A Delphi Consensus Panel Report

5. Clinical Decision Making in Inflammatory Bowel Disease Mimics: Practice Management from Inflammatory Bowel Disease LIVE.

6. S1207 Clinical Decision Making in Mimickers of IBD: Practice Management From IBD Live

12. Mo1478: PARASTOMAL PYODERMA GANGRENOSUM IN IBD: PREVALENCE, TREATMENT, AND CLINICAL OUTCOMES IN A TERTIARY CENTER

13. Mo1538: BASELINE PERIPHERAL BLOOD EOSINOPHILIA PREDICTS DECREASED RESPONSE TO INITIAL ANTI-TNF BIOLOGIC THERAPY IN IBD

14. Sa1587: GRANULOMA PRESENCE AT INITIAL SURGERY PREDICTS NEED FOR REPEAT SURGERY INDEPENDENT OF RUTGEERTS’ ENDOSCOPIC SCORE IN CROHN'S DISEASE

25. Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)

26. IBD MIMICS PRESENTED AT IBD LIVE: WHEN IT IS NOT INFLAMMATORY BOWEL DISEASE

27. S3341 When It Is Not Inflammatory Bowel Disease: IBD Mimics Presented at IBD Live

30. Of Mice and Men

31. Acute physiologic effects of N95 respirator use on gastroenterologists performing simulated colonoscopy

32. Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients: An Observational, Prospective Cohort Study Interim Analysis

33. Targeted next-generation sequencing supports serrated epithelial change as an early precursor to inflammatory bowel disease–associated colorectal neoplasia

34. Ustekinumab-Induced Remission of Two Cases of Refractory Cutaneous Crohn’s Disease

35. Fr554 DISPARITIES IN TREATMENT AND HEALTHCARE UTILIZATION BEETWEEN INFLAMMATORY BOWEL DISEASE PATIENTS FOLLOWED AT A REFERRAL UNIVERSITY CENTER AND COMMUNITY HOSPITALS

36. Su524 PERIPHERAL BLOOD MONOCYTOSIS IS A NOVEL BIOMARKER OF LONG-TERM DISEASE SEVERITY IN PEDIATRIC-ONSET INFLAMMATORY BOWEL DISEASE

37. Su507 INCREASED HOSPITAL ADMISSIONS ARE ASSOCIATED WITH DECREASED GUT MICROBIOME DIVERSITY AND DECREASED FAECALOBACTERIUM IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE STUDY

38. Sa487 DERMATOLOGIC MANIFESTATIONS OF IBD: ASSOCIATION WITH NATURAL HISTORY AND BIOMARKERS OF SEVERITY

39. Su515 THE ASSOCIATION OF ORAL VANCOMYCIN ADMINISTRATION AND FAECAL MICROBIOME COMPOSITION IN PATIENTS WITH CROHN'S DISEASE

40. 249 POSITIVE GLUTEN SENSITIVITY SEROLOGIES AND THE IMPACT OF GLUTEN FREE DIET IN PATIENTS WITH IBD

41. Monocytosis Is a Biomarker of Severity in Inflammatory Bowel Disease: Analysis of a 6-Year Prospective Natural History Registry

48. S0810 Dual Biologic Therapy for the Treatment of Severe/Refractory Inflammatory Bowel Disease: Intravenous Immunoglobulin in Combination With Standard Biologic Agents

49. S0809 Is There a Benefit of Immunomodulator and Anti-TNF Combination Therapy Over Monotherapy in the Real World, Long-Term Management of IBD? Assessing Multiyear Treatment Persistence and Mucosal Healing

50. S0890 Can IBD Medications Counteract the Negative Effects of a Deleterious, High Sugar Diet?

Catalog

Books, media, physical & digital resources